1 Report Prologue
2 Market Introduction
2.1 Scope of Study 15
2.2 Research Objective 15
2.3 List of Assumptions 15
3 Research Methodology
3.1 Research Process 18
3.2 Primary Research 18
3.3 Secondary Research 19
3.4 Market Size Estimation 21
4 Market Dynamics
4.1 Introduction 23
4.2 Drivers 23
4.2.1 Increasing Prevalence of Pemphigus Vulgaris Globally 23
4.2.2 Growing Financial Support by Various Private and Government Organizations for Research of Diseases 23
4.2.3 Increasing Geriatric Population 23
4.3 Restraints 24
4.3.1 Lack of Awareness Among the Countries 24
4.3.2 High Cost of Treatment 24
4.4 Opportunities 24
4.4.1 Advancements in Treatments 24
4.5 Challenge 24
4.5.1 Adverse Side–Effects of the Treatment 24
5 Market Factor Analysis
5.1 Overview 26
5.1.1 R&D 26
5.1.2 Manufacturing 26
5.1.3 Distribution & Sales 26
5.1.4 Post–Sales Monitoring 27
5.2 Porter’s Five Forces Model 27
5.2.1 Overview 27
5.2.2 Bargaining Power of Suppliers 28
5.2.3 Bargaining Power of Buyers 28
5.2.4 Threat of New Entrants 28
5.3 Threat of Substitutes 28
5.4 Intensity of Rivalry 28
5.5 Investment Opportunity Analysis 29
6 Global Pemphigus Vulgaris Market, By Treatment
6.1 Introduction 31
6.2 Corticosteroids 33
6.3 Immunosuppressants 33
6.4 Biological Therapies 34
6.5 Intravenous Immunoglobulin (IVIG) Therapy 34
7 Global Pemphigus Vulgaris Market, By Route of Administration
7.1 Introduction 36
7.2 Intravenous 38
7.3 Subcutaneous 38
7.4 Oral 38
8 Global Pemphigus Vulgaris Market, By End–user
8.1 Introduction 40
8.2 Hospitals & Clinics 41
8.3 Specialty Dermatology Clinics 41
8.4 Research & Academic Laboratories 41
9 Global Pemphigus Vulgaris Market, By Region
9.1 Introduction 44
9.2 Americas 46
9.2.1 North America 48
9.2.1.1 US 50
9.2.1.2 Canada 51
9.2.2 South America 52
9.3 Europe 53
9.3.1 Western Europe 55
9.3.1.1 Germany 57
9.3.1.2 UK 58
9.3.1.3 France 59
9.3.1.4 Italy 60
9.3.1.5 Spain 61
9.3.1.6 Rest of Western Europe 62
9.3.2 Eastern Europe 63
9.4 Asia–Pacific 64
9.4.1 Japan 66
9.4.2 China 67
9.4.3 India 68
9.4.4 Australia 69
9.4.5 Republic of Korea 70
9.4.6 Rest of Asia–Pacific 71
9.5 Rest of the World 72
10 Competitive Landscape
10.1 Introduction 74
11 Company Profiles
11.1 Almirall, SA 76
11.1.1 Company Overview 76
11.1.2 Financial Overview 76
11.1.3 Products/Services Offered 77
11.1.4 Key Developments 77
11.1.5 SWOT Analysis 77
11.1.6 Key Strategy 77
11.2 Argenx SE 78
11.2.1 Company Overview 78
11.2.2 Financial Overview 78
11.2.3 Products/Services Offered 78
11.2.4 Key Developments 78
11.2.5 SWOT Analysis 79
11.2.6 Key Strategy 79
11.3 Biogen Inc. 80
11.3.1 Company Overview 80
11.3.2 Financial Overview 80
11.3.3 Products/Services Offered 81
11.3.4 Key Developments 81
11.3.5 SWOT Analysis 81
11.3.6 Key Strategy 81
11.4 F. Hoffmann–La Roche 82
11.4.1 Company Overview 82
11.4.2 Financial Overview 82
11.4.3 Products/Services Offered 83
11.4.4 SWOT Analysis 83
11.4.5 Key Strategy 83
11.5 Syntimmune 84
11.5.1 Company Overview 84
11.5.2 Financial Overview 84
11.5.3 Products/Services Offered 85
11.5.4 Key Developments 85
11.5.5 SWOT Analysis 85
11.5.6 Key Strategy 85
11.6 Pfizer Inc. 86
11.6.1 Company Overview 86
11.6.2 Financial Overview 86
11.6.3 Products/Services Offered 87
11.6.4 Key Developments 87
11.6.5 SWOT Analysis 87
11.6.6 Key Strategy 87
11.7 Novartis AG 88
11.7.1 Company Overview 88
11.7.2 Financial Overview 88
11.7.3 Products/Services Offered 89
11.7.4 Key Developments 89
11.7.5 SWOT Analysis 89
11.7.6 Key Strategy 89
11.8 Sanofi 90
11.8.1 Company Overview 90
11.8.2 Financial Overview 90
11.8.3 Products/Services Offered 91
11.8.4 Key Developments 91
11.8.5 SWOT Analysis 91
11.8.6 Key Strategy 91
11.9 Janssen Global Services, LLC 92
11.9.1 Company Overview 92
11.9.2 Financial Overview 92
11.9.3 Products/Services Offered 93
11.9.4 Key Developments 93
11.9.5 SWOT Analysis 93
11.9.6 Key Strategy 93
11.10 Principia Biopharma 94
11.10.1 Company Overview 94
11.10.2 Financial Overview 94
11.10.3 Products/Services Offered 94
11.10.4 Key Developments 94
11.10.5 SWOT Analysis 94
11.10.6 Key Strategy 94
12 Appendix
12.1 Discussion Blue Print 96
13 List of Tables
TABLE 1 LIST OF ASSUMPTIONS 14
TABLE 2 PRIMARY INTERVIEWS 17
TABLE 3 GLOBAL PEMPHIGUS VULGARIS MARKET, BY TREATMENT 2023–2030 (USD MILLION) 31
TABLE 4 GLOBAL PEMPHIGUS VULGARIS MARKET, FOR CORTICOSTEROIDS 2023–2030 (USD MILLION) 32
TABLE 5 GLOBAL PEMPHIGUS VULGARIS MARKET, FOR IMMUNOSUPPRESSANTS 2023–2030 (USD MILLION) 32
TABLE 6 GLOBAL PEMPHIGUS VULGARIS MARKET, FOR BIOLOGICAL THERAPIES 2023–2030 (USD MILLION) 33
TABLE 7 GLOBAL PEMPHIGUS VULGARIS MARKET, FOR INTRAVENOUS IMMUNOGLOBULIN (IVIG) THERAPY 2023–2030 (USD MILLION) 33
TABLE 8 GLOBAL PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 35
TABLE 9 GLOBAL PEMPHIGUS VULGARIS MARKET, FOR INTRAVENOUS 2023–2030 (USD MILLION) 36
TABLE 10 GLOBAL PEMPHIGUS VULGARIS MARKET, FOR SUBCUTANEOUS 2023–2030 (USD MILLION) 36
TABLE 11 GLOBAL PEMPHIGUS VULGARIS MARKET, FOR ORAL 2023–2030 (USD MILLION) 36
TABLE 12 GLOBAL PEMPHIGUS VULGARIS MARKET, BY END–USER 2023–2030 (USD MILLION) 38
TABLE 13 GLOBAL PEMPHIGUS VULGARIS MARKET, FOR HOSPITALS & CLINICS 2023–2030 (USD MILLION) 39
TABLE 14 GLOBAL PEMPHIGUS VULGARIS MARKET, FOR SPECIALTY DERMATOLOGY CLINICS 2023–2030 (USD MILLION) 39
TABLE 15 GLOBAL PEMPHIGUS VULGARIS MARKET, FOR RESEARCH & ACADEMIC LABORATORIES 2023–2030 (USD MILLION) 39
TABLE 16 GLOBAL PEMPHIGUS VULGARIS MARKET, BY REGION 2023–2030 (USD MILLION) 42
TABLE 17 AMERICAS: PEMPHIGUS VULGARIS MARKET, BY REGION 2023–2030 (USD MILLION) 43
TABLE 18 AMERICAS: PEMPHIGUS VULGARIS MARKET, BY TREATMENT 2023–2030 (USD MILLION) 43
TABLE 19 AMERICAS: PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 44
TABLE 20 AMERICAS: PEMPHIGUS VULGARIS MARKET, BY END USER 2023–2030 (USD MILLION) 44
TABLE 21 NORTH AMERICA: PEMPHIGUS VULGARIS MARKET, BY COUNTRY 2023–2030 (USD MILLION) 45
TABLE 22 NORTH AMERICA: PEMPHIGUS VULGARIS MARKET, BY TREATMENT 2023–2030 (USD MILLION) 46
TABLE 23 NORTH AMERICA: PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 46
TABLE 24 NORTH AMERICA: PEMPHIGUS VULGARIS MARKET, BY END USER 2023–2030 (USD MILLION) 46
TABLE 25 US: PEMPHIGUS VULGARIS MARKET, BY TREATMENT 2023–2030 (USD MILLION) 47
TABLE 26 US: PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 47
TABLE 27 US: PEMPHIGUS VULGARIS MARKET, BY END USER 2023–2030 (USD MILLION) 47
TABLE 28 CANADA: PEMPHIGUS VULGARIS MARKET, BY TREATMENT 2023–2030 (USD MILLION) 48
TABLE 29 CANADA: PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 48
TABLE 30 CANADA: PEMPHIGUS VULGARIS MARKET, BY END USER 2023–2030 (USD MILLION) 48
TABLE 31 SOUTH AMERICA: PEMPHIGUS VULGARIS MARKET, BY TREATMENT 2023–2030 (USD MILLION) 49
TABLE 32 SOUTH AMERICA: PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 49
TABLE 33 SOUTH AMERICA: PEMPHIGUS VULGARIS MARKET, BY END USER 2023–2030 (USD MILLION) 49
TABLE 34 EUROPE: PEMPHIGUS VULGARIS MARKET, BY REGION 2023–2030 (USD MILLION) 50
TABLE 35 EUROPE: PEMPHIGUS VULGARIS MARKET, BY TREATMENT 2023–2030 (USD MILLION) 51
TABLE 36 EUROPE: PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 51
TABLE 37 EUROPE: PEMPHIGUS VULGARIS MARKET, BY END USER 2023–2030 (USD MILLION) 51
TABLE 38 WESTERN EUROPE: PEMPHIGUS VULGARIS MARKET, BY COUNTRY 2023–2030 (USD MILLION) 52
TABLE 39 WESTERN EUROPE: PEMPHIGUS VULGARIS MARKET, BY TREATMENT 2023–2030 (USD MILLION) 53
TABLE 40 WESTERN EUROPE: PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 53
TABLE 41 WESTERN EUROPE: PEMPHIGUS VULGARIS MARKET, BY END USER 2023–2030 (USD MILLION) 53
TABLE 42 GERMANY: PEMPHIGUS VULGARIS MARKET, BY TREATMENT 2023–2030 (USD MILLION) 54
TABLE 43 GERMANY: PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 54
TABLE 44 GERMANY: PEMPHIGUS VULGARIS MARKET, BY END USER 2023–2030 (USD MILLION) 54
TABLE 45 UK: PEMPHIGUS VULGARIS MARKET, BY TREATMENT 2023–2030 (USD MILLION) 55
TABLE 46 UK: PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 55
TABLE 47 UK: PEMPHIGUS VULGARIS MARKET, BY END USER 2023–2030 (USD MILLION) 55
TABLE 48 FRANCE: PEMPHIGUS VULGARIS MARKET, BY TREATMENT 2023–2030 (USD MILLION) 56
TABLE 49 FRANCE: PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 56
TABLE 50 FRANCE: PEMPHIGUS VULGARIS MARKET, BY END USER 2023–2030 (USD MILLION) 56
TABLE 51 ITALY: PEMPHIGUS VULGARIS MARKET, BY TREATMENT 2023–2030 (USD MILLION) 57
TABLE 52 ITALY: PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 57
TABLE 53 ITALY: PEMPHIGUS VULGARIS MARKET, BY END USER 2023–2030 (USD MILLION) 57
TABLE 54 SPAIN: PEMPHIGUS VULGARIS MARKET, BY TREATMENT 2023–2030 (USD MILLION) 58
TABLE 55 SPAIN: PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 58
TABLE 56 SPAIN: PEMPHIGUS VULGARIS MARKET, BY END USER 2023–2030 (USD MILLION) 58
TABLE 57 REST OF WESTERN EUROPE: PEMPHIGUS VULGARIS MARKET, BY TREATMENT 2023–2030 (USD MILLION) 59
TABLE 58 REST OF WESTERN EUROPE: PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 59
TABLE 59 REST OF WESTERN EUROPE: PEMPHIGUS VULGARIS MARKET, BY END USER 2023–2030 (USD MILLION) 59
TABLE 60 EASTERN EUROPE: PEMPHIGUS VULGARIS MARKET, BY TREATMENT 2023–2030 (USD MILLION) 60
TABLE 61 EASTERN EUROPE: PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 60
TABLE 62 EASTERN EUROPE: PEMPHIGUS VULGARIS MARKET, BY END USER 2023–2030 (USD MILLION) 60
TABLE 63 ASIA-PACIFIC: PEMPHIGUS VULGARIS MARKET, BY COUNTRY/REGION 2023–2030 (USD MILLION) 61
TABLE 64 ASIA-PACIFIC: PEMPHIGUS VULGARIS MARKET, BY TREATMENT 2023–2030 (USD MILLION) 62
TABLE 65 ASIA-PACIFIC: PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 62
TABLE 66 ASIA-PACIFIC: PEMPHIGUS VULGARIS MARKET, BY END USER 2023–2030 (USD MILLION) 62
TABLE 67 JAPAN: PEMPHIGUS VULGARIS MARKET, BY TREATMENT 2023–2030 (USD MILLION) 63
TABLE 68 JAPAN: PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 63
TABLE 69 JAPAN: PEMPHIGUS VULGARIS MARKET, BY END USER 2023–2030 (USD MILLION) 63
TABLE 70 CHINA: PEMPHIGUS VULGARIS MARKET, BY TREATMENT 2023–2030 (USD MILLION) 64
TABLE 71 CHINA: PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 64
TABLE 72 CHINA: PEMPHIGUS VULGARIS MARKET, BY END USER 2023–2030 (USD MILLION) 64
TABLE 73 INDIA: PEMPHIGUS VULGARIS MARKET, BY TREATMENT 2023–2030 (USD MILLION) 65
TABLE 74 INDIA: PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 65
TABLE 75 INDIA: PEMPHIGUS VULGARIS MARKET, BY END USER 2023–2030 (USD MILLION) 65
TABLE 76 AUSTRALIA: PEMPHIGUS VULGARIS MARKET, BY TREATMENT 2023–2030 (USD MILLION) 66
TABLE 77 AUSTRALIA: PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 66
TABLE 78 AUSTRALIA: PEMPHIGUS VULGARIS MARKET, BY END USER 2023–2030 (USD MILLION) 66
TABLE 79 REPUBLIC OF KOREA: PEMPHIGUS VULGARIS MARKET, BY TREATMENT 2023–2030 (USD MILLION) 67
TABLE 80 REPUBLIC OF KOREA: PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 67
TABLE 81 REPUBLIC OF KOREA: PEMPHIGUS VULGARIS MARKET, BY END USER 2023–2030 (USD MILLION) 67
TABLE 82 REST OF ASIA-PACIFIC: PEMPHIGUS VULGARIS MARKET, BY TREATMENT 2023–2030 (USD MILLION) 68
TABLE 83 REST OF ASIA-PACIFIC: PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 68
TABLE 84 REST OF ASIA-PACIFIC: PEMPHIGUS VULGARIS MARKET, BY END USER 2023–2030 (USD MILLION) 68
TABLE 85 REST OF THE WORLD: PEMPHIGUS VULGARIS MARKET, BY TREATMENT 2023–2030 (USD MILLION) 69
TABLE 86 REST OF THE WORLD: PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 69
TABLE 87 REST OF THE WORLD: PEMPHIGUS VULGARIS MARKET, BY END USER 2023–2030 (USD MILLION) 69
14 List of Figures
FIGURE 1 GLOBAL PEMPHIGUS VULGARIS MARKET: MARKET STRUCTURE 15
FIGURE 2 RESEARCH PROCESS 17
FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 20
FIGURE 4 SUPPLY CHAIN: GLOBAL PEMPHIGUS VULGARIS MARKET 25
FIGURE 5 PORTER’S FIVE FORCES ANALYSIS: GLOBAL PEMPHIGUS VULGARIS MARKET 26
FIGURE 6 GLOBAL PEMPHIGUS VULGARIS MARKET, BY TREATMENT 2023 & 2030 (USD MILLION) 31
FIGURE 7 GLOBAL PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION 2023 & 2030 (USD MILLION) 35
FIGURE 8 GLOBAL PEMPHIGUS VULGARIS MARKET, BY END-USER 2023 & 2030 (USD MILLION) 38
FIGURE 9 GLOBAL PEMPHIGUS VULGARIS MARKET SHARE, BY REGION 2023 (%) 42
FIGURE 10 AMERICAS: PEMPHIGUS VULGARIS MARKET SHARE, BY REGION 2023 (%) 43
FIGURE 11 NORTH AMERICA: PEMPHIGUS VULGARIS MARKET SAHRE, BY COUNTRY 2023 (%) 45
FIGURE 12 EUROPE: PEMPHIGUS VULGARIS MARKET SHARE, BY REGION 2023 (%) 50
FIGURE 13 WESTERN EUROPE: PEMPHIGUS VULGARIS MARKET SAHRE, BY CONTRY 2023 (%) 52
FIGURE 14 ASIA-PACIFIC: PEMPHIGUS VULGARIS MARKET, BY COUNTRY/REGION 2023 (%) 61
FIGURE 15 TOP PLAYERS IN THE GLOBAL PEMPHIGUS VULGARIS MARKET 71
